InsidersTradesSigma
Discover the detailed record of transactions filed by 최희경, Chief Executive Officer. Insider active across 2 companies, notably 지투지바이오. Aggregated, 5 disclosures have been logged. The latest transaction was filed on 25 March 2026 — Purchase. Regulator: DART (FSS). The full history is openly available.
5 of 5 declarations
Choi Hee-kyung is the Executive Director at G2G Bio, a company specializing in biotechnology. In this role, she oversees the company's operations and strategy. G2G Bio is recognized for its innovations in the biotechnology field.